Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Utility of icobrain for brain volumetry in multiple sclerosis clinical practice.
Nguyen AL, Sormani MP, Horakova D, Havrdova EH, Barnett MH, De Stefano N, Battaglini M, Vaneckova M, Lui E, Gaillard F, Desmond PM, Prime H, Datta M, Van der Walt A, Jokubaitis VG, Podevyn F, Zivadinov R, Weinstock-Guttman B, D'hooghe MB, Nagels G, Van Pesch V, Laureys G, Van Hijfte L, Lechner-Scott J, Patti F, Cristiano E, Rojas JI, Sima DM, Van Hecke W, Kalincik T, Butzkueven H. Nguyen AL, et al. Among authors: vaneckova m. Mult Scler Relat Disord. 2024 Dec;92:106148. doi: 10.1016/j.msard.2024.106148. Epub 2024 Nov 8. Mult Scler Relat Disord. 2024. PMID: 39536619 Free article.
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
Uher T, Horakova D, Tyblova M, Zeman D, Krasulova E, Mrazova K, Seidl Z, Vaneckova M, Krasensky J, Weinstock-Guttman B, Ramanathan M, Havrdova E, Zivadinov R. Uher T, et al. Among authors: vaneckova m. Mult Scler. 2016 May;22(6):770-81. doi: 10.1177/1352458515601903. Epub 2015 Sep 11. Mult Scler. 2016. PMID: 26362893 Clinical Trial.
Reliable measurements of brain atrophy in individual patients with multiple sclerosis.
Smeets D, Ribbens A, Sima DM, Cambron M, Horakova D, Jain S, Maertens A, Van Vlierberghe E, Terzopoulos V, Van Binst AM, Vaneckova M, Krasensky J, Uher T, Seidl Z, De Keyser J, Nagels G, De Mey J, Havrdova E, Van Hecke W. Smeets D, et al. Among authors: vaneckova m. Brain Behav. 2016 Jul 19;6(9):e00518. doi: 10.1002/brb3.518. eCollection 2016 Sep. Brain Behav. 2016. PMID: 27688944 Free PMC article.
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
Uher T, Vaneckova M, Krasensky J, Sobisek L, Tyblova M, Volna J, Seidl Z, Bergsland N, Dwyer MG, Zivadinov R, De Stefano N, Sormani MP, Havrdova EK, Horakova D. Uher T, et al. Among authors: vaneckova m. Mult Scler. 2019 Apr;25(4):541-553. doi: 10.1177/1352458517742739. Epub 2017 Nov 16. Mult Scler. 2019. PMID: 29143562
Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study.
Horakova D, Uher T, Krasensky J, Seidl Z, Ribbens A, Van Hecke W, Billiet T, Koendgen H, Freudensprung U, Hyde R, Vaneckova M. Horakova D, et al. Among authors: vaneckova m. Mult Scler Relat Disord. 2020 Nov;46:102543. doi: 10.1016/j.msard.2020.102543. Epub 2020 Sep 28. Mult Scler Relat Disord. 2020. PMID: 33296966 Free article.
Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis.
Uher T, Krasensky J, Malpas C, Bergsland N, Dwyer MG, Kubala Havrdova E, Vaneckova M, Horakova D, Zivadinov R, Kalincik T. Uher T, et al. Among authors: vaneckova m. Neurol Neuroimmunol Neuroinflamm. 2021 Mar 16;8(3):e979. doi: 10.1212/NXI.0000000000000979. Print 2021 May. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33727311 Free PMC article. Clinical Trial.
169 results